FBXW7 and hepatocellular carcinoma: miR-223 has been detected to be upregulated in T-ALL, GC, NSCLC, and HCC in vitro and in vivo, mediating therapeutic resistance presumably through FBXW7-regulated proliferation, apoptosis, EMT, and autophagy.